Status:
COMPLETED
Evaluation by MRI of Anal Canal Cell Carcinoma: is There Predictive Factor?
Lead Sponsor:
Fondation Hôpital Saint-Joseph
Conditions:
Anal Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
Anal canal cell carcinoma is a very rare cancer but well treated. If the morphological test are well established in the initial evaluation, it's not the case of the follow up evaluation particularly b...
Eligibility Criteria
Inclusion
- patient with anal canal cell carcinoma histologically proved
- patient with initial MRI and follow up MRI in Hospital St Joseph's radiology yard.
- patient for whom a radio chemotherapy treatment decision was taken.
Exclusion
- patients with already metastatic lesions
Key Trial Info
Start Date :
April 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2017
Estimated Enrollment :
87 Patients enrolled
Trial Details
Trial ID
NCT03469596
Start Date
April 1 2017
End Date
December 31 2017
Last Update
March 22 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Paris Saint Joseph
Paris, Île-de-France Region, France, 75014